Table 3.

Jobelyn^® attenuates monosodium glutamate-induced increase in activity of liver enzymes in mice

Treatments groups	ALT (U/L)	AST (U/L)	ALP (U/L)
VEH (10 mL/kg)	6.92 ± 0.40	15.98 ± 0.69	23.17 ± 1.69
MSG (8 g/kg)	19.33 ± 0.61*	50.04 ± 1.75*	61.82 ± 2.95*
MSG (8 g/kg) + JB (5 mg/kg)	9.19 ± 0.39#	23.47 ± 0.81#	31.36 ± 2.42#
MSG (8 g/kg) + JB (10 mg/kg)	9.34 ± 0.25#	20.58 ± 1.17#	33.46 ± 2.30#
MSG (8 g/kg) + JB (20 mg/kg)	10.85 ± 0.41#	22.78 ± 1.57#	29.08 ± 2.13#

Each value represents the mean ± SEM of grouped mice (n = 3). *p < 0.05 compared to vehicle group, ^#p < 0.05 compared to MSG (8 g/kg) (one-way ANOVA followed by Bonferroni post-hoc test)

VEH vehicle, MSG monosodium glutamate, JB Jobelyn^®